hw5soln - 2. Should a pharmaceutical firm invest in the...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: 2. Should a pharmaceutical firm invest in the following project? For 10 years, the nominal costs will be $1 million a year and in this period, there will be no revenues. From year 11 to 20, the nominal revenues will be $2 million per year and the costs will be $250,000. Assume that the discount rate is 3%. Year Costs Revenues Total Discounted Value 1 1,000,000 $ - $ (1,000,000) $ (970,874) $ 2 1,000,000 $ - $ (1,000,000) $ (942,596) $ 3 1,000,000 $ - $ (1,000,000) $ (915,142) $ 4 1,000,000 $ - $ (1,000,000) $ (888,487) $ 5 1,000,000 $ - $ (1,000,000) $ (862,609) $ 6 1,000,000 $ - $ (1,000,000) $ (837,484) $ 7 1,000,000 $ - $ (1,000,000) $ (813,092) $ 8 1,000,000 $ - $ (1,000,000) $ (789,409) $ 9 1,000,000 $ - $ (1,000,000) $ (766,417) $ 10 1,000,000 $ - $ (1,000,000) $ (744,094) $ 11 250,000 $ 2,000,000 $ 1,750,000 $ 1,264,237 $ 12 250,000 $ 2,000,000 $ 1,750,000 $ 1,227,415 $ 13 250,000 $ 2,000,000 $ 1,750,000 $ 1,191,665 $ 14 250,000 $ 2,000,000 $ 1,750,000 $ 1,156,956 $ 15...
View Full Document

This note was uploaded on 01/18/2012 for the course HPAM 8600 taught by Professor Ferig during the Spring '11 term at UGA.

Page1 / 2

hw5soln - 2. Should a pharmaceutical firm invest in the...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online